ProMIS Neurosciences has reported six-month interim safety and biomarker data [...]
ProMIS Neurosciences has reported the first human evidence that its [...]
Sysmex Europe has launched its HISCL automated immunoassay platform for [...]
Galimedix Therapeutics has completed a phase 1 study of its [...]
In a significant shift for Alzheimer’s care, the Alzheimer’s Association [...]